Literature DB >> 29709732

Treatment initiation strategies for syringe exchange referrals to methadone maintenance: A randomized clinical trial.

Michael Kidorf1, Robert K Brooner2, Jeannie-Marie Leoutsakos2, Jessica Peirce2.   

Abstract

This randomized clinical trial evaluated the efficacy of three treatment initiation strategies for improving retention to methadone maintenance for opioid-dependent individuals referred from a syringe exchange program (SEP). New admissions (n = 212) were randomly assigned to one of three 3-month initiation strategies: 1) Low Threshold (LTI), 2) Voucher Reinforcement (VRI), or 3) Standard Care (SCI). LTI was modeled on interim methadone maintenance to transition SEP admissions to the structure of medication-assisted treatment while maximizing exposure to methadone pharmacotherapy. VRI used monetary incentives to reinforce adherence to pharmacotherapy and adaptive counseling. SCI participants received standard methadone dosing and adaptive counseling. All participants were stabilized on methadone pharmacotherapy with a target dose of 80 mg. Following the initiation phase, participants in each condition received standard adaptive counseling from months 4-6. Results showed that most participants failed to achieve the target methadone dose. While no condition differences were observed in retention rates over the 3-month and 6-month observation periods, participants across conditions exhibited reductions in objective and self-report measures of drug use. Results support the benefits of referring syringe exchangers to methadone maintenance, and demonstrate the challenge of retaining these individuals in treatment.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Methadone maintenance; Syringe exchange; Treatment initiation; Treatment retention

Mesh:

Substances:

Year:  2018        PMID: 29709732     DOI: 10.1016/j.drugalcdep.2018.03.009

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  6 in total

1.  Recruitment into a Clinical Trial of People Living with Uncontrolled HIV Infection Who Inject Drugs: a Site Case Report from the CTN 67 CHOICES Study.

Authors:  Hansel Tookes; Jessica Ucha; Allan E Rodriguez; Edward Suarez; Elizabeth Alonso; Lisa R Metsch; Daniel J Feaster; Tyler S Bartholomew; Kim A Hoffman; P Todd Korthuis
Journal:  J Behav Health Serv Res       Date:  2021-09-29       Impact factor: 1.475

2.  Sexual-risk reduction following the referral of syringe exchange registrants to methadone maintenance: Impact of gender and drug use.

Authors:  Michael Kidorf; Robert K Brooner; Haijuan Yan; Jessica Peirce
Journal:  J Subst Abuse Treat       Date:  2021-01-09

3.  Racial differences in overdose training, naloxone possession, and naloxone administration among clients and nonclients of a syringe services program.

Authors:  A A Jones; J N Park; S T Allen; K E Schneider; B W Weir; D Hunt; S G Sherman
Journal:  J Subst Abuse Treat       Date:  2021-04-15

4.  Evaluating comparative effectiveness of psychosocial interventions adjunctive to opioid agonist therapy for opioid use disorder: A systematic review with network meta-analyses.

Authors:  Danielle Rice; Kimberly Corace; Dianna Wolfe; Leila Esmaeilisaraji; Alan Michaud; Alicia Grima; Bradley Austin; Reuben Douma; Pauline Barbeau; Claire Butler; Melanie Willows; Patricia A Poulin; Beth A Sproule; Amy Porath; Gary Garber; Sheena Taha; Gord Garner; Becky Skidmore; David Moher; Kednapa Thavorn; Brian Hutton
Journal:  PLoS One       Date:  2020-12-28       Impact factor: 3.240

5.  Syringe service program-based telemedicine linkage to opioid use disorder treatment: protocol for the STAMINA randomized control trial.

Authors:  Dennis P Watson; James A Swartz; Lisa Robison-Taylor; Mary Ellen Mackesy-Amiti; Kim Erwin; Nicole Gastala; Antonio D Jimenez; Monte D Staton; Sarah Messmer
Journal:  BMC Public Health       Date:  2021-03-31       Impact factor: 3.295

Review 6.  Retention Strategies for Medications for Opioid Use Disorder in Adults: A Rapid Evidence Review.

Authors:  Brian Chan; Emily Gean; Irina Arkhipova-Jenkins; Jennifer Gilbert; Jennifer Hilgart; Celia Fiordalisi; Kimberly Hubbard; Irene Brandt; Elizabeth Stoeger; Robin Paynter; Philip Todd Korthuis; Jeanne-Marie Guise
Journal:  J Addict Med       Date:  2021 Jan-Feb 01       Impact factor: 4.647

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.